新宙邦开启港股IPO！

Core Viewpoint - The company plans to issue H-shares and apply for a listing on the Hong Kong Stock Exchange to advance its globalization strategy, pending approval from relevant regulatory bodies [1] Company Developments - The company has achieved batch applications for hydrogen fluoride ether and perfluoropolyether products, establishing partnerships with multiple clients, indicating potential growth in the fluorinated liquid business [1] - The company’s lithium hexafluorophosphate self-supply ratio currently stands at 50%-70%, which meets the current production needs for electrolytes, with expectations to increase this ratio after the completion of technical upgrades by the end of 2025 [2] - The company has completed the phased capacity construction for core fluorinated liquid products, with hydrogen fluoride ether capacity at approximately 3,000 tons and perfluoropolyether capacity at about 2,500 tons [3] - The company reported a revenue of approximately 4.25 billion yuan for the first half of 2025, a year-on-year increase of about 18.6%, with net profit around 480 million yuan, up 16.4% [3] Industry Insights - The electrolyte sector has entered a rebound phase since Q3, with prices of lithium hexafluorophosphate rising, and new contracts will reference the latest market prices [4] - The company maintains an optimistic outlook for 2026, anticipating a tight supply-demand situation and rational price returns, influenced by fluctuations in lithium carbonate and other material prices [4] - The company has plans for capital expenditures and aims to enhance its overseas supply chain, focusing on factories in Malaysia and Poland, while also improving domestic efficiency and developing high-value new projects [4]